Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 29, 2018 16:52 ET | Source: Genmab A/S

Genmab Announces Positive Topline Results in Phase III MAIA Study of Daratumumab in Front Line Multiple Myeloma

Company Announcement Phase III MAIA study of daratumumab in combination with lenalidomide and dexamethasone in front line multiple myeloma met the primary endpoint (PFS) at a pre-planned interim...
October 21, 2018 17:46 ET | Source: Genmab A/S

Genmab Announces Positive Topline Results in Phase III CASSIOPEIA Study of Daratumumab in Front Line Multiple Myeloma

Company Announcement Phase III CASSIOPEIA study of daratumumab in combination with bortezomib, thalidomide and dexamethasone in front line multiple myeloma met the primary endpoint of stringent...
October 16, 2018 06:45 ET | Source: Genmab A/S

Genmab Announces Net Sales of DARZALEX® (daratumumab) for Third Quarter of 2018

Company Announcement Net sales of DARZALEX in the third quarter of 2018 totaled USD 498 millionGenmab will receive royalties on worldwide net sales from Janssen Biotech, Inc. Copenhagen, Denmark;...
October 08, 2018 18:51 ET | Source: Genmab A/S

Genmab and Seattle Genetics Announce Tisotumab Vedotin Data to be Presented at ESMO 2018 Congress

Media Release Data presented from updated analysis of full innovaTV 201 expansion cohort in recurrent or metastatic cervical cancer Copenhagen, Denmark and BOTHELL, Wash., October 9, 2018 –...
September 26, 2018 01:24 ET | Source: Genmab A/S

Genmab’s 2018 Capital Markets Day

Media Release Genmab’s 2018 Capital Markets Day taking place today, will also be webcast liveNumber of Genmab internal speakers, including Executive ManagementTopics include updates on products,...
September 25, 2018 03:02 ET | Source: Genmab A/S

Genmab's Financial Calendar for 2019

Company Announcement Copenhagen, Denmark; September 25, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announces its financial calendar for 2019 as follows: EVENTDATEPublication of the Annual Report...
September 21, 2018 15:16 ET | Source: Genmab A/S

Grant of Restricted Stock Units and Warrants to Genmab employees

Company Announcement Copenhagen, Denmark; September 21, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that at a board meeting the board decided to grant 11,770 restricted stock units and...
September 19, 2018 08:59 ET | Source: Genmab A/S

Genmab to Host Capital Markets Day

Media Release Review of Genmab’s progress and operationsEvent will take place at Genmab’s R&D Center in Utrecht, the NetherlandsEvent will be webcast live with an archived version available ...
September 18, 2018 12:16 ET | Source: Genmab A/S

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement Copenhagen, Denmark; September 18, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) will increase its share capital by 18,414 shares as a consequence of the exercise of employee...
September 06, 2018 09:00 ET | Source: Genmab A/S

Genmab to Present at Morgan Stanley 16th Annual Global Healthcare Conference

Media Release Copenhagen, Denmark; September 6, 2018 – Genmab A/S (Nasdaq Copenhagen: GEN) announced today that its CEO, Jan van de Winkel, Ph.D., will give a company update at the Morgan Stanley...